TY  - JOUR
AU  - Blanco, Jose R
AU  - Rivero-Juarez, Antonio
PY  - 2016
DO  - 10.1080/14787210.2016.1243466
UR  - http://hdl.handle.net/10668/10489
T2  - Expert review of anti-infective therapy
AB  - Hepatocellular carcinoma (HCC) is a serious complication inthe natural history of chronic hepatitis C virus (HCV), andcirrhosis is the strongest risk factor [1]. Although differentrandomized clinical trials [2–4], meta-analyses [5–8], and sys-tematic...
LA  - en
PB  - Taylor & Francis
KW  - Direct acting antivirals hepatitis c
KW  - HCC development
KW  - Hepatocellular carcinoma
KW  - Interferon-free regimen
KW  - Sustained virological response
KW  - Antiviral Agents
KW  - Carcinoma, Hepatocellular
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Liver Cirrhosis
KW  - Liver Neoplasms
KW  - Risk
KW  - Sustained Virologic Response
TI  - The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?
TY  - research article
VL  - 14
ER  -